Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10086387 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta
Conditions: Osteogenesis Imperfecta Type II;   Osteogenesis Imperfecta Type III
Intervention: Biological: Mesenchymal Stromal Cells

Indicates status has not been verified in more than two years